Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Neoplasm Metastasis
×
Standard of Care
×
Clear all
Filters
3
NCT01468623
2023-07-19
PROFUSE
Myriad Genetic Laboratories, Inc.
Phase 4
Terminated
51 enrolled